Furfaro, Federica
Vuitton, Lucine
Fiorino, Gionata
Koch, Stephane
Allocca, Mariangela
Gilardi, Daniela
Zilli, Alessandra
D’Amico, Ferdinando
Radice, Simona
Chevaux, Jean-Baptiste
Schaefer, Marion
Chaussade, Stanislas
Danese, Silvio http://orcid.org/0000-0001-7341-1351
Peyrin-Biroulet, Laurent http://orcid.org/0000-0003-2536-6618
Article History
Accepted: 15 May 2020
First Online: 11 June 2020
Competing interests
: The authors disclose the following: F.F. received consultancy fees from MSD, AbbVie, Janssen and Amgen. L.V. has received lecture fees from Abbvie, Ferring, MSD, Pfizer, Janssen and Takeda; consulting fees from Abbvie, Ferring and Gilead; and research grants from MSD, Pfizer and Takeda. G.F. received consultancy fees from Ferring, MSD, AbbVie, Takeda, Janssen, Amgen, Sandoz, Samsung Bioepis, Celltrion, Mylan and Roche. S.K. has received lecture fees from Abbvie, Mayoli, MSD, FujiFilm. M.A. received consultancy fees from Nikkiso Europe and lecture fees from Janssen, Abbvie and Pfizer. D.G. received consultancy fees from Nikkiso, Sofar Spa, Boiler Spa, J&J, Pfizer, Takeda and Roche. S.D. has served as a speaker, consultant and advisory board member for Schering-Plough, Abbott (AbbVie) Laboratories, Merck, UCB Pharma, Ferring, Cellerix, Millenium Takeda, Nycomed, Pharmacosmos, Actelion, a Wasserman, Genentech, Grunenthal, Pfizer, AstraZeneca, Novo Nordisk, Cosmo Pharmaceuticals, Vifor and Johnson & Johnson. L.P.-B. has received consulting fees from Merck, AbbVie, Janssen, Genentech, Mitsubishi, Ferring, Norgine, Tillots, Vifor, Therakos, Pharmacosmos, Pilège, BMS, UCB pharma, Hospira, Celltrion, Takeda, Biogaran, Boerhinger Ingelheim, Lilly, Pfizer, HAC-Pharma, Index Pharmaceuticals, Amgen, and Sandoz and lecture fees from Merck, AbbVie, Takeda, Janssen, Takeda, Ferring, Norgine, Tillots, Vifor, Therakos, Mitsubishi and HAC pharma. A.Z., F.D., J.-B.C., M.S., S.C. and S.R. declare no competing interests.
Free to read: This content has been made available to all.